Trial Profile
A Double-Masked, Placebo-Controlled, Randomized, Phase II Clinical Trial To Assess The Efficacy Of IVIEW-1201 In The Treatment Of Acute Adenoviral Conjunctivitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Feb 2024
Price :
$35
*
At a glance
- Drugs Povidone iodine (Primary)
- Indications Adenovirus infections; Viral-conjunctivitis
- Focus Therapeutic Use
- Sponsors iView Therapeutics
- 06 Feb 2024 Status changed from recruiting to completed.
- 15 Mar 2023 Planned End Date changed from 1 Dec 2020 to 31 Dec 2023.
- 15 Mar 2023 Planned primary completion date changed from 1 Nov 2020 to 31 Dec 2023.